M2 marker CD163 is lower than injured controls for both treatment groups but did not reach statistical significance with our limited power for the 14d treatment group in the ipsilateral hemisphere.
← all excerpts
Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI.
1
—
—